Case Report: Resolution of remitting seronegative symmetrical synovitis with pitting edema during nivolumab therapy for gastric cancer

The anti-programmed cell death-1 (PD-1) antibody nivolumab has been shown to significantly prolong the survival of patients with unresectable advanced or recurrent gastric cancer (AGC). However, immune-related adverse events (irAEs), which show different profiles from those of cytotoxic agents or co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohmura, Hirofumi, Kondo, Moe, Uenomachi, Masato, Ariyama, Hiroshi, Ito, Mamoru, Tsuchihashi, Kenji, Ayano, Masahiro, Niiro, Hiroaki, Akashi, Koichi, Baba, Eishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586790/
https://www.ncbi.nlm.nih.gov/pubmed/37869081
http://dx.doi.org/10.3389/fonc.2023.1260818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586790/
https://www.ncbi.nlm.nih.gov/pubmed/37869081
http://dx.doi.org/10.3389/fonc.2023.1260818

Ejemplares similares